Transcript File

Chronic Obstructive Pulmonary
Disease (COPD)
A process characterized by the presence of chronic bronchitis,
emphysema, or both, leading to the development of airway
obstruction
What is COPD?
What is COPD?
 COPD is a serious lung disease that makes it hard to
breathe.

airways are partly blocked, which makes it hard to get air in and
out
 Emphysema- damage to air sacs in lungs
 Chronic bronchitis- swelling of air passages that lead
to lungs
Statistics
 3rd leading cause of death in the U.S.
 Over 12 million are currently diagnosed and an
estimated additional 12 million have it but haven’t
been diagnosed
6
7
8
Etiology
I am doing it, my etiology
COPD
 Causes
 Smoking (90%)
 Environmental factors


Air pollution, confined kitchen areas
Genetics: α1-antitrypsin
Produced in liver
 Protects lung against elastase
 Elastase breaks down elastin
 No elastin= no recoil
 Deficiency  liver and lung failure
 Less than 1% of COPD patients
 Without smoking

Emphysema
 Imbalance of antiproteases
& proteases
Normal
Cigarette smoke
oxidation
α1-antitrypsin deficiency
Cigarette smoke
recruit neutrophils
Increased proteases
Emphysema
 α1-antitrypsin deficiency & increased proteases
 Collagen and elastin destruction
 Flabby lung
 ↓ recoil
 Abnormal enlargement & destruction of alveoli
 ↓ SA
Chronic Bronchitis
 Cigarette smoke irritants inflammation of airway
 Hyperplasia and hypertrophy of mucus glands
 Hypertrophy of goblet cells increased mucus
 Smaller airway + more mucus = mucus plug
14
Case Study
 SB
 Age 62
 Smoking history: 1 pack/day for 46 years
 Quit 1 year ago
Pathophysiology
Physiology of Pulmonary System
 Functions
 Acid-Base Balance
 Synthesize arachidonic acid



ACE converts Ang. I to Ang. II
Gas exchange


Prostaglandins, Leukotrienes
Surfactant
Immune defense
Gas Exchange
Basic Pathophysiology
 Emphysema
 Permanent enlargement of acini with alveolar destruction
 Closure of small airways
 Primary: Alpha-1 Antitrypsin deficiency (inherited)
 Secondary: Inability to inhibit proteolytic enzymes (smoking,
etc.)
 Chronic Bronchitis
 Hypersecretion of thick immobile mucus and productive cough
 Mucus obstruction of bronchioles
 Continuous bronchial inflammation
* Common for patients to display both types
Inflammation of COPD
Emphysema
 Pathophysiology
 Smoke irritants cause inflammation of the epithelial
 Protease activity increased by cytokines


Elastase, Cathepsin, Metalloprotease.
Imbalance of proteases and anti-proteases cause a breakdown
on elastin in alveolar septa
Reduced elastic recoil and expiration
 Eliminated portions of pulmonary capillary bed
 Diminished airway caliber



Air-trapping (causing barrel chest)
Bronchoconstriction (caused by persistent inflammation)
Emphysema
Chronic Bronchitis
 Pathophysiology
 Smoking/irritants stimulate mucus production
 Ciliary function impaired= reduced mucus clearance
 Bacterial growth and inflammation= more mucus production
Bronchial/Bronchiolar walls thicken
 Persistence involves bronchospasms and narrowing of the
airways



Obstuction (Mucus + wall thickening + lumen narrowing)
Airway collapse in expiration
Chronic Bronchitis
25
Effects on Energy
 Affect on energy metabolism
 Protein degradation - Cachexia
Acute Exacerbations
 Accelerated loss of lung function and poor quality of
life
 Severe Pulmonary Hypertension
 PA:A ratio >1 =pulmonary artery enlargement
 Other effects:



Increase in dyspnea, hypercapnia, cough, and/or sputum
production
New strains of bacteria or viruses; environmental factors
Ischemia, Heart Failure, Thromboembolism
Cor Pulmonale


Late stages
From chronic PAH:
Low PAO2 /Hypoxia causes pulmonary vasoconstriction
 Can be reversed if PACO2 is cleared but…
 Resistance to PA blood flow



Increased workload of RV
Peripheral edema noted
Signs & Symptoms
Emphysema
 No mucus or cough
 Barrel chest
 ↓ lung plasticity & hyperinflation
 Pressure around the lung greater

than pressure in the lung
 Lung collapse
 Trapped air
 Expand anteroposteriorly
Emphysema
 Breathing Habits
 Lean forward
Stabilizes chest
 Allows max expansion
 Accessory muscles


Pursed lips

More air out before lung collapse
Emphysema
 Older (>50)
 Underweight, cachectic
 Late cor pulmonale
 Decreased DLCO
 ↓ alveolar SA
 “Pink puffers”
Chronic Bronchitis
 Hypersecretion of mucus and chronic productive
cough for 3 months for 2 consecutive years
 Shorteness of breath, even at rest
 Wheezing
 Normal weight
but often overweight
Chronic Bronchitis
 V/Q Mismatch
 V= Ventilation; air that reaches alveoli
 Q=Perfusion; blood that reaches alveoli
 Hypoxemia
 Cyanosis around lips
 “Blue bloaters”
 Stimulates renal secretion of erythropoietin
 High hematocrit
 Vasoconstriction hypertension early cor pulmonale
Case Study
 “I am gasping for air”
 “I am coughing up a lot of phlegm”
 “I am always short of breath”
 No cyanosis or clubbing
 Wheezing
 Uses accessory muscles at rest
Diagnosis
Spirometry
 Pt inhales & then exhales as
 much and as fast as possible
 Measures
 FVC
 FEV1

FEV1/FVC
Spirometry
Spirometry
 Post-bronchodilator FEV1 / FVC <.7 confirms airflow
limitation that is not fully reversible
Diffusion of Lung Capacity
 DLCO
 Patient inhales small amount of CO
 Compare the amount exhaled by amount inhaled
 Determines amount absorbed
 ↓ indicative of emphysema but not chronic bronchitis
Prognosis
Prognosis
 Not curable
 Slow damage
 Prevent exacerbation

acute change in symptoms to needing a change in therapy
 dyspnoea
 cough and/or sputum
43
Quality of Life
 ADLs
 http://www.youtube.com/watch?v=G3vmSDXH
wMI
Case Study
 “I’m hardly able to do anything for myself…my
husband had to help me out of the shower this
morning.”
Treatment
Treatment
 No cure
 Quite smoking
 Walk to strengthen muscles needed for breathing
 Avoid cold air
 Avoid smoke, make sure no one smokes in your home
 Reduce air pollution by getting rid of fireplace smoke
and other irritants
48
Medications: Bronchodilators
 Inhalers (Bronchodilators) work to relax the muscles
around the airways, to help open them and make it
easier to breathe.
 Some Inhalers include: ipratropium (Atrovent),
tiotropium (Spiriva), salmeterol (Serevent),
formoterol (Foradil), or albuterol
Medications: Inhaled Steroids
 Reduce lung inflammation
 Most commonly used inhaled corticosteroids:
fluticasone propionate, budesonide, and
beclometasone dipropionate
Pulmonary Rehab
 Multidisciplinary program including
 Medical management
 Exercise
 Breathing retraining
 Education
 Emotional support
 Nutrition counseling
Oxygen Therapy
 Ways to test need:
 Arterial Blood Gas Test
 Oxometer
 Oxygen Delivery
 Oxygen Concentrators
 Compressed Oxygen Cylinders
 Liquid Oxygen Cylinders
Oxygen Concentrator
Compressed Oxygen Cylinder
Liquid Oxygen Cylinder
Surgery
 Only a few patients benefit from surgical treatment
 Surgery to remove parts of the diseased lung can help
the less diseased areas work better
 Lung transplant for severe cases
Case Study-Treatment
 Oxygen therapy
 Endotracheal intubation
 Enteral feeding due to high residuals
Alternative Medicine
 Extracts from ivy or thyme are popular in many
European countries
 Clinical Trial: Ivy leaf extract vs. Ambroxol tablets
(conventional treatment).

Vital Capacity: Weighted Mean Difference 0.24 (-0.22–0.7)
Alternative Medicine
 Honey
 Thyme Oil
 Xiao Chuan (XCP)
Nutritional Assessment
Physical Observations
 Barrel Chest
Physical Observations
• Finger clubbing
• Cyanosis
Client History
 Medications (e.g, steroids):
 Nutritional supplements (e.g., herbals):
 Previous Oxygen use
 Adherence with previous nutrition prescription:
Successes and barriers
Anthropometrics
 Weight Status
 Body Composition
Emphysema
 Chronic Bronchitis

 Energy Needs
Energy Needs in Stable COPD
 Stress factor to account for inflammation
 Prevent obesity (chronic bronchitis)
 Increased work of breathing
 Chronic infection
 Chest physical therapy
 Pulmonary rehabilitation exercise programs
 Altered metabolism (anabolism, catabolism)
Anthropometrics
• Weight Status
• Cor Pulmonale
• Body Composition
• Emphysema
• Chronic Bronchitis
• Energy Needs
• Bone density screening
• 18% of men and 30% of women had osteoporosis
• 42% of men and 41% of women had osteopenia
Food History
 Preferences
 Usual meal pattern
 Dietary restrictions
 Food allergies and intolerances/Food aversions
 Supplement intake
 Appetite
ADLs
 Symptoms interfering with ability to consume
adequate intake:







Shortness of breath
Fatigue
Ability to secure and prepare food
Taste and smell changes
Chewing or swallowing difficulties
Pain when eating
Nausea and vomiting
69
Case Study
• Poor appetite
• Coughing makes it hard to eat
• Food doesn’t taste good
• PES statement: Inadequate oral intake related to side effects
to acute exacerbation of COPD as evidenced by weight loss
and anorexia.
MNT
MNT Goals
 Facilitate nutritional well-being
 Lean body mass to adipose tissue ratio
 Correct fluid imbalances
 Prevent Osteoporosis
 Manage drug-nutrient interactions
Facilitate nutritional well-being
 Possible Problems
 Solutions

Fatigue

Eat high calorie foods when hungry

Coughing during meals

Eat slowly

Aspiration

Feeling bloated or full

Include more fiber

Dry mouth

Drink adequate fluids with meal

Inability to prepare own foods

Select easy to prepare meals or seek
assistance
Lean body mass to adipose ratio
 Energy Needs
 Prevent excess weight gain in early stages
 Calorie control if weight loss is needed

Harris-Benedict equation
 Women
• 655 + (9.6 * kg) + (1.8 * cm) - (4.7 * age)

Men
• 66 + (13.7 * kg) + (5 * cm) - (6.8 * age)

Stress factor = 1.2-1.3

Exercise factor if needed
Lean body mass to adipose ratio
 Macronutrients
 Protein


1.2-1.7 g/kg
Proportions to balance respiratory quotient
15-20% from protein
 30-45% from fat
 40-55% from carbohydrates


Oral nutritional support

“There is limited evidence to support consumption of a particular
macronutrient composition of medical food supplementation.”
-NCM
77
Lean body mass to adipose ratio
 Vitamin and minerals
 Vitamin C

Vitamin D and K supplementation

Calcium

Restrictions in fluid-electrolyte imbalances
Na+ restrictions
 K+ restrictions

Correct fluid imbalances
 Normal
 30-35 ml/kg
 Cor pulmonale
 Fluid restrictions
 Na+ restrictions
Prevent Osteoporosis
 Why?
 Decreased physical activity
 Inhaled steroids?
 Scan for osteoporosis/osteopenia
 Ensure adequate calcium consumption
Drug-nutrient Interactions
 Ipratropium (Atrovent)
 Anticholinergic drugs
 Decreased secretions Dry mouth
 Contains Soy lecithin
 Albuterol
 Theophylline
Ø Bronchodilators that suppress the appetite
COPD: Ain’t nobody got time for that.